ena-STUDY-AstraZeneca-11-02-2019-14:52:22:117-188
Heterogeneity of response to fulvestrant and PI3-Kinase inhibitors of an estrogen receptor-positive GEMM-derived Pten p53 null transplantable breast tumour model
Heterogeneity of response to fulvestrant and PI3-Kinase inhibitors of an estrogen receptor-positive GEMM-derived Pten p53 null transplantable breast tumour model